Model Details(Unspecified organ) tumor
Model Name |
(Unspecified organ) tumor | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Chemical/Drug : 3'-azido-3'-deoxythymidine (AZT) |
Tumor Synonyms |
hematopoietic neoplasm • hematopoietic tumor • male reproductive tissue neoplasm • male reproductive tissue tumor • female reproductive tissue tumor • female reproductive tissue neoplasm |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| (Unspecified organ) | Female |
13.6% (3 of 22 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
15.6% (5 of 32 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
14.8% (8 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
16.7% (4 of 24 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
22.2% (6 of 27 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
19.6% (10 of 51 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
4.3% (1 of 23 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
10.7% (3 of 28 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
7.8% (4 of 51 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
7.7% (2 of 26 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
10.7% (3 of 28 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
9.3% (5 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
50% (7 of 14 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
21.4% (3 of 14 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
0% (0 of 8 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
50% (4 of 8 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
25% (4 of 16 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
18.75% (3 of 16 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
10% (1 of 10 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
10% (1 of 10 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Female |
25% (12 of 48 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
0% (0 of 19 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
5.3% (1 of 19 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
15.4% (2 of 13 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
21.4% (3 of 14 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
6.7% (1 of 15 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
13.3% (2 of 15 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
0% (0 of 14 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
0% (0 of 14 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| (Unspecified organ) | Male |
4.9% (3 of 61 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |